Results of TRIO-15, a multicenter, open-label, phase II study of the efficacy and safety of ganitumab in patients with recurrent platinum-sensitive ovarian cancer

T. M. Davidson, C. L. Lebreton, A. E.Wahner Hendricksen, H. J. Atkinson, M. C. Larson, A. L. Oberg, D. M. Provencher, J. A. Glaspy, B. Y. Karlan, D. J. Slamon, G. E. Konecny, I. L. Ray-Coquard

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Results of TRIO-15, a multicenter, open-label, phase II study of the efficacy and safety of ganitumab in patients with recurrent platinum-sensitive ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences